[Cerebellar soap bubble lesions and mediastinal lymph nodes].
Ramos
Antonio
A
Unidad de Enfermedades Infecciosas, Servicio de Medicina Interna III, Hospital Universitario Puerta de Hierro, Universidad Autónoma de Madrid, Madrid, España. antrammar@yahoo.es
de Reina
Laura
L
Duca
Ana
A
Saucedo
Gertrudis
G
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D001922:Brain Abscess / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology / Q000601:surgery; D002526:Cerebellar Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology / Q000601:surgery; D003131:Combined Modality Therapy; D003399:Craniotomy; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008482:Mediastinum; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D020306:Tuberculosis, Central Nervous System / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D014388:Tuberculosis, Lymph Node / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology
D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin